Trials / Completed
CompletedNCT00387556
Ondansetron Reduce Vomiting Associated With Ketamine PSA
Does Ondansetron Reduce the Incidence of Vomiting When Used in Conjunction With Ketamine During Procedural Sedation in the Pediatric Emergency Department
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 268 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 1 Year – 21 Years
- Healthy volunteers
- Accepted
Summary
Ondansetron, a commonly used anti-vomiting medication, may reduce the occurrence of vomiting associated with ketamine during procedural sedation in the pediatric emergency department.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ondansetron | ondansetron (0.15 mg/kg/dose; maximum dose 4 mg) |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2006-10-13
- Last updated
- 2013-05-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00387556. Inclusion in this directory is not an endorsement.